Joshua K. Sabari, MD, director of High Reliability Organization Initiatives at NYU Langone Health's Perlmutter Cancer Center, ...

Panelists discuss how IDH inhibitors, particularly ivosidenib combined with azacitidine, represent potentially the greatest ...

Insurance coverage for prescription digital therapeutics has been notably uneven, with many health care leaders lacking ...

The new provision of Medicaid is set to go into effect by January 1, 2027, which leaves only a year and a half for those on Medicaid to adjust. Although some are exempt from needing to provide proof ...

Panelists discuss how managed care organizations can leverage prescription digital therapeutics as cost-reduction tools to ...

In part 1 of an interview, Xiaoxi Zhao, PhD, former associate economist at RAND Corporation and lead investigator of "Pricing and Insurance Networks in Outpatient Surgery Markets, ...

Adequate outpatient follow-up within 30 days significantly reduces 30-day all-cause hospital readmissions, impacting hospital finances and patient care quality. The study analyzed 83 studies, ...

Recently incarcerated individuals with HIV face challenges in achieving sustained viral suppression (SVS) due to social conditions and health care access issues. Young and frequently incarcerated ...

Panelists discuss how venetoclax management requires standardized approaches to duration, bone marrow biopsy timing, growth factor use, and azole antifungal selection, with practices varying ...

Guideline-directed medical therapy (GDMT) is used to treat patients with heart failure (HF) with reduced ejection fraction (HFrEF), although optimal dosing and titration of medications remain ...

“Given the profound impact [long COVID] can have on the health and well-being of adolescents and the lack of available treatments, these findings support vaccination as an effective and meaningful ...

Up to 4 million people may lose coverage, increasing uninsured rates, especially in non-Medicaid expansion states and among ...